Megestrol Acetate
Who holds supplier records for Megestrol Acetate? 8 organisations hold a current record for Megestrol Acetate: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), Italy (1), United States (1) and Netherlands (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Megestrol Acetate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/megestrol-acetate
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Megestrol Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 12662 · latest filing Sept 1997
- Pharmacia & Upjohn, Inc.United StatesCEPActive DMF 1817 · latest filing Nov 1971
- TAIZHOU TAIFA PHARMACEUTICALS CO LTDCEPActive DMF 24583 · latest filing Jan 2011
- TAPI NL BVNetherlandsCEPActive DMF 12687 · latest filing Oct 1997
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEPActive DMF 24592 · latest filing Jan 2011
- JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTDChinaActive DMF 27596 · latest filing Nov 2013
- ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTDChinaActive DMF 35601 · latest filing Jan 2021
- XIANJU SYNSEA BIOPHA CO. LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Megestrol Acetate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| XIANJU SYNSEA BIOPHA CO. LTD. Taizhou | CN | CEP 2020-293 - Rev 01 Megestrol acetate, Micronised | Mar 2026 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | CEP 2002-181 - Rev 10 Megestrol acetate, Micronised and fine powder | Jan 2026 | Inspected Jul 2026 Italy |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2012-010 - Rev 05 Megestrol acetate | Dec 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2009-086 - Rev 02 Megestrol acetate | Mar 2025 | — |
| Taizhou Taifa Pharmaceuticals Co., Ltd. Xianju | CN | R1-CEP 2012-011 - Rev 00 Megestrol acetate | Nov 2018 | — |
| Pharmacia & Upjohn Company Kalamazoo | US | R1-CEP 2008-020 - Rev 01 Megestrol acetate, Micronised | Sept 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Megestrol Acetate are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- United States · Inactive DMF 12157 · filed Oct 1996
- SOCIETA ITALIANA CORTICOSTEROIDI SPAInactive DMF 6673 · filed Nov 1986
- Germany · Inactive DMF 5296 · filed Mar 1984
- GLAXO LABORATORIES SAInactive DMF 2494 · filed Jul 1975
- SYNTEX USA INCInactive DMF 1738 · filed Jun 1971
Overview
Megestrol Acetate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201139).
Chemical identity
- IUPAC name
- [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
- Canonical SMILES
- CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
- InChIKey
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N
- Synonyms
- 5071, BDH 1298, BDH-1298, Chronopil, Megace, Megace es, Megesterol acetate, Megestrol, Megestrol 17.alpha.-acetate, Megestrol acetate, NSC-71423, SC 10363
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Progestin
- Chemical structure
- Progesterone Congeners
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Megestrol Acetate?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Megestrol Acetate: Farmabios S.p.A. (Italy), Pharmacia & Upjohn, Inc. (United States), TAIZHOU TAIFA PHARMACEUTICALS CO LTD, TAPI NL BV (Netherlands), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD, JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTD (China), ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTD (China) and XIANJU SYNSEA BIOPHA CO. LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Megestrol Acetate Drug Master Files are active?
Farmabios S.p.A. (DMF 12662), Pharmacia & Upjohn, Inc. (DMF 1817), TAIZHOU TAIFA PHARMACEUTICALS CO LTD (DMF 24583), TAPI NL BV (DMF 12687), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 24592), JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTD (DMF 27596) and ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTD (DMF 35601). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Megestrol Acetate records mean?
5 organisations have only inactive Type II DMFs for Megestrol Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Megestrol Acetate have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Megestrol Acetate on the EDQM register, including XIANJU SYNSEA BIOPHA CO. LTD. Taizhou (CN), FARMABIOS S.p.A Gropello Cairoli (IT), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), TAPI NL B.V. Amsterdam (NL), Taizhou Taifa Pharmaceuticals Co., Ltd. Xianju (CN) and Pharmacia & Upjohn Company Kalamazoo (US). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Megestrol Acetate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Megestrol Acetate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.